The Valley Desk

NCT03899792 · Interventional trial

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Infantile Fibrosarcoma, Infantile Myofibromatosis, Medullary Thyroid Cancer, Papillary Thyroid Cancer, Soft Tissue Sarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov